EBITDA margin společnosti Genocea Biosciences Inc
Jaká je hodnota metriky EBITDA margin společnosti Genocea Biosciences Inc?
Hodnota metriky EBITDA margin společnosti Genocea Biosciences Inc je -2,788.23%
Jaká je definice metriky EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Genocea Biosciences Inc
Čemu se věnuje společnost Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Firmy s metrikou ebitda margin podobnou společnosti Genocea Biosciences Inc
- Hodnota metriky EBITDA margin společnosti Inovio Pharmaceuticals je -2,850.67%
- Hodnota metriky EBITDA margin společnosti WayPoint Biomedical je -2,849.14%
- Hodnota metriky EBITDA margin společnosti UroGen Pharma Ltd je -2,821.65%
- Hodnota metriky EBITDA margin společnosti Syros Pharmaceuticals je -2,796.41%
- Hodnota metriky EBITDA margin společnosti Saint Jean Carbon je -2,796.21%
- Hodnota metriky EBITDA margin společnosti Volt Carbon Technologies Inc je -2,796.21%
- Hodnota metriky EBITDA margin společnosti Genocea Biosciences Inc je -2,788.23%
- Hodnota metriky EBITDA margin společnosti AssetOwl je -2,784.76%
- Hodnota metriky EBITDA margin společnosti Sprott Physical Silver Trust je -2,779.39%
- Hodnota metriky EBITDA margin společnosti Nex Metals Explorations je -2,766.11%
- Hodnota metriky EBITDA margin společnosti Ascendis Pharma A/S je -2,759.32%
- Hodnota metriky EBITDA margin společnosti GobiMin je -2,734.72%
- Hodnota metriky EBITDA margin společnosti Transition Metals je -2,718.30%